Phase 3Terminated
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
- Sponsor
- Glaukos Corporation (Industry)
- Enrollment
- 92 enrolled
- Conditions
- Keratoconus
- Interventions
- riboflavin solution; placebo solution; KXL System
- Ages
- children, adults, older adults
- Registry
- NCT01972854
Full record on ClinicalTrials.gov
From the registry
The objectives of this study are to evaluate the safety and efficacy of corneal collagen cross-linking performed with VibeX (riboflavin ophthalmic solution) and the KXL System as compared to placebo in impeding the progression of, and/or reducing, maximum corneal curvature.
Primary outcomes
- Change in Kmax from baseline
History
Last registry update
Study completion
Primary completion
Started
Registered